Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still Counts.
ModernaModerna(US:MRNA) Barrons·2026-11-06 21:04

核心观点 - Moderna营收超出预期,业绩受到国际新冠疫苗需求的提振 [1] 营收表现 - 公司营收高于市场预期 [1] - 业绩增长主要动力来自国际新冠疫苗需求 [1]

Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still Counts. - Reportify